EPO and anemia: In patients with chronic kidney disease (CKD), anemia develops gradually, primarily due to inadequate renal synthesis of erythropoietin, disturbances in iron balance in the body (which may be in part due to increased hepcidin levels), blood loss, decreased red blood cell survival and inflammation [3,4].